Aaron Weaver

Aaron N.
D.
Weaver is currently an Independent Non-Executive Director at Bionomics Ltd., a Director at Interactive Strength, Inc., a Director at Endogena Therapeutics, Inc., a Director at Leaf4life LLC, a Member-Supervisory Board at MagForce AG, the Head-Capital Markets at Apeiron Investments SCA, and a Principal at Apeiron Investment Group Ltd.
Previously, he was a Director at Alto Neuroscience, Inc. and served as the Senior General Counsel & Investor Relations Lead at ATAI Life Sciences AG from 2019 to 2021.
Mr. Weaver completed his undergraduate degree at The University of Queensland in 2003 and his graduate degree at Queensland University of Technology in 2006.